(Q36543096)

14 August 2017

1 reference

title

Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence (English)

1 reference

14 August 2017

main subject

anti-retroviral agent

0 references

1 reference

4

Julio Montaner

1 reference

14 August 2017

2

Thomas Kerr

1 reference

14 August 2017

5

Evan Wood

1 reference

14 August 2017

3

Nadia Fairbairn

1 reference

14 August 2017

Benjamin Maas

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Expert Opinion on Drug Metabolism & Toxicology

14 August 2017

published in

1 reference

14 August 2017

volume

2

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

533-543

1 reference

Opioid substitution and HIV/AIDS treatment and prevention

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Barriers to use of free antiretroviral therapy in injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

HIV drug interactions: the good, the bad, and the other.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Methadone--metabolism, pharmacokinetics and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Effect of opioid dependence pharmacotherapies on zidovudine disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Principles and practice of HIV-protease inhibitor pharmacoenhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Decreased methadone effect after ritonavir initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

A controlled trial of buprenorphine treatment for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Antiretroviral therapy for drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

Efavirenz decreases methadone blood concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.533

21 January 2018

Identifiers

DOI

10.1517/17425255.2.4.533

1 reference

14 August 2017

1 reference